Finance

Lists
Why is 128940 down 3,77%?
Dive Deeper
128940:KRX
Hanmi Pharm Co Ltd
382 500,00 KRW
-3,77%
(-15 000,00) 1D
19-окт., 13:36:26 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 128940...
Open
389 500 KRW
High
394 500 KRW
Low
370 000 KRW
Mkt. cap
4,90 трлн
Avg. vol.
124,40 миң
Volume
74,27 миң
Dividend
0,52%
Quarterly dividend
500 KRW
Ex-dividend date
2026-ж., 30-мар.
P/E ratio
22,37
52-wk high
647 000 KRW
52-wk low
302 000 KRW
EPS
17 100 KRW
Shares outstanding
12,81 млн
No. of employees
2 миң
Open
389 500 KRW
High
394 500 KRW
Low
370 000 KRW
Mkt. cap
4,90 трлн
Avg. vol.
124,40 миң
Volume
74,27 миң
Dividend
0,52%
Quarterly dividend
500 KRW
Ex-dividend date
2026-ж., 30-мар.
P/E ratio
22,37
52-wk high
647 000 KRW
52-wk low
302 000 KRW
EPS
17 100 KRW
Shares outstanding
12,81 млн
No. of employees
2 миң
News stories
From web sources and news partners
Profile
Hanmi Pharm Co., Ltd. is a South Korean pharmaceutical company that is headquartered in Seoul. Wikipedia
About Hanmi Pharm Co Ltd
CEO-
Employees2,34 миң
Founded1973
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
362,35 млд
432,96 млд
392,93 млд
467,25 млд
Cost of goods sold
156,75 млд
172,48 млд
175,64 млд
164,04 млд
Cost of revenue
156,75 млд
172,48 млд
175,64 млд
164,04 млд
Research and development expenses
54,65 млд
51,66 млд
57,12 млд
52,08 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
95,88 млд
125,55 млд
106,52 млд
120,03 млд
Operating expense
153,33 млд
205,73 млд
171,55 млд
179,72 млд
Total operating expenses
310,08 млд
378,22 млд
347,19 млд
343,76 млд
Operating income
52,27 млд
54,74 млд
45,74 млд
123,49 млд
Other non operating income
-1,73 млд
664,20 млн
2,62 млд
-4,88 млд
EBT including unusual items
52,26 млд
58,49 млд
55,38 млд
120,14 млд
EBT excluding unusual items
51,55 млд
57,99 млд
55,26 млд
119,61 млд
Income tax expense
6,85 млд
4,43 млд
4,30 млд
36,06 млд
Effective tax rate
13,10%
7,58%
7,76%
30,01%
Other operating expenses
-
-
-
-
Net income
40,13 млд
48,12 млд
45,49 млд
83,31 млд
Net profit margin
11,07%
11,11%
11,58%
17,83%
Earnings per share
-
-
-
-
Interest and investment income
1,67 млд
2,51 млд
2,62 млд
2,77 млд
Interest expense
-3,94 млд
-3,65 млд
-3,41 млд
-3,35 млд
Net interest expenses
-2,27 млд
-1,14 млд
-783,67 млн
-588,23 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
76,84 млд
80,03 млд
70,44 млд
148,58 млд
Gain or loss from assets sale
-13,32 млн
-39,36 млн
3,68 млн
40,66 млн
AI content may include mistakes. Learn more
Google колдонмолору